Delvys Rodriguez-Abreu, MD, discusses findings from the final analysis of the phase 3 KEYNOTE-189 study in metastatic nonsquamous non–small cell lung cancer.
Delvys Rodriguez-Abreu, MD
Advertisement
Articles by Delvys Rodriguez-Abreu, MD
Delvys Rodriguez-Abreu, MD, discusses the final analysis of the phase 3 KEYNOTE-189 study in metastatic nonsquamous non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Rodriguez-Abreu on the Final Analysis of the KEYNOTE-189 Trial in NSCLCPublished: June 2nd 2020 | Updated:
Dr. Rodriguez-Abreu on Updated Results From the KEYNOTE-189 Trial in NSCLCPublished: June 5th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5